Clavulanate Lithium

CAS: 61177-44-4

Ref. 3D-FC46584

Produktinformation

• Name: Clavulanate Lithium
• Synonyme: 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)-, 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, (2R,3Z,5R)-, 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, [2R-(2α,3Z,5α)]-, Lithium (2R-(2alpha,3(Z),5alpha))-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo(3.2.0)heptane-2-carboxylate, Lithium clavulanate

Beschreibung

Clavulanate lithium is an antibiotic that inhibits the growth of bacteria by binding to penicillin-binding proteins. It is a prodrug that is hydrolyzed in vivo to clavulanic acid, its active form. The inhibitory properties of clavulanate lithium are similar to those of amoxicillin, but it has greater activity against pseudomonas aeruginosa and Staphylococcus aureus. Clavulanate lithium has been shown to increase the plasma concentrations of amoxicillin when used in combination with this drug. It is also effective against a variety of bacterial infections, including Escherichia coli, Proteus mirabilis, Enterobacter cloacae, and Staphylococcus aureus isolates. Clavulanate lithium can be used as an adjunct therapy for the treatment of respiratory tract infections caused by common viruses such as influenza and rhinovirus. Clavulanate

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 206.1 g/mol
• Formel: C₈H₉NO₅•Li
• Reinheit: Min. 95%
• Farbe/Form: Powder